(Total Views: 131)
Posted On: 11/21/2019 12:30:43 PM
Post# of 21237

$SNY News Article - Pivotal data from Phase 3 study of sutimlimab in cold agglutinin disease to be presented at ASH 2019 late-breaking session https://marketwirenews.com/news-releases/pivo...06051.html


My Twitter: WhyteStocks